Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Top Medical Cannabis Stocks To Buy? 2 To Watch For Long Term Investing
02:30pm, Sunday, 05'th Jun 2022
These Could Be The Best Medical Cannabis Stocks To Watch The post Top Medical Cannabis Stocks To Buy? 2 To Watch For Long Term Investing appeared first on Marijuana Stocks | Cannabis Investments and N
3 Great Dividend Stocks to Buy in June
07:04am, Sunday, 05'th Jun 2022
Investors should be able to count on recurring income with these stocks.
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
05:43am, Sunday, 05'th Jun 2022
These were the industry's bestsellers last year, but how long can they stay on top?
2 Top Dividend Kings to Buy for the Long Haul
11:23am, Saturday, 04'th Jun 2022
These two healthcare stocks have delivered ever higher dividends to their shareholders for decades.
Two-minute drill: TJX, CIEN & ABBV
06:25pm, Friday, 03'rd Jun 2022
Joanne Feeney, Advisors Capital Management partner and portfolio manager, joins ‘Closing Bell: Overtime' to discuss some of her top names for investors' portfolios in the current environment.
3 Reasons to Buy This Blue-Chip Stock
11:45am, Friday, 03'rd Jun 2022
2022 has been characterized by a paradigm shift from growth stocks to dividend stocks.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Friday, 03'rd Jun 2022
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
‘I needed something to do’: How working in retirement is being embraced by older adults and companies
06:23pm, Wednesday, 01'st Jun 2022 MarketWatch
The tight labor market and Zoom are helping baby boomers work the way they want.
1 Green Flag for AbbVie in 2022 and 1 Red Flag
03:15pm, Wednesday, 01'st Jun 2022 The Motley Fool
As U.S. doors open to more competition, investors will want to take a deeper look into the product portfolio.
My 3 Favorite Dividend Stocks to Buy in June
09:52am, Wednesday, 01'st Jun 2022 The Motley Fool
All three are beating the market so far this year.
A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?
12:58pm, Sunday, 29'th May 2022 MarketWatch
Pfizer’s promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030. Lilly’s got a drug in development, too.
3 Dividend Stocks You Can Buy and Hold Forever
11:31am, Sunday, 29'th May 2022 The Motley Fool
Their strong underlying businesses should keep the quarterly payouts flowing to shareholders.
3 Dividend Stocks You Can Buy and Hold Forever
07:31am, Sunday, 29'th May 2022
Their strong underlying businesses should keep the quarterly payouts flowing to shareholders.
Income Method: Become Financially Independent, Stress-Free
01:00pm, Saturday, 28'th May 2022 Seeking Alpha
Being financially independent is a prerequisite for retirees, but can be a great stress reducer for younger folks who are several years away from retirement. Find out more here.
Wall Street Breakfast: What Moved Markets
10:53am, Saturday, 28'th May 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
